The FTSE 100 index climbed 10 points to 4,196 this morning after AstraZenica received US Food and Dr...
The FTSE 100 index climbed 10 points to 4,196 this morning after AstraZenica received US Food and Drug Administration approval for Crestor branded cholesterol drug.
AstraZenica led the gainers with a 66p rise to £25.55.
Dixons continued its rise on the back of strong sales caused by hot weather, adding another 2.75p to 133.75p.
AngloAmerica added 20p to 1160.5p as South African-based companies saw share prices soar to six-month highs on hopes that global economic recovery will increase demand for metals such as gold and platinum.
Scottish & Newcastle dropped 20.25p to 367.75p as the shares went ex-dividend.
Lloyds TSB dropped 8.5p to 435.5p on news that it is in talks with ANZ bank over the disposal of its New Zealand operations.
The FTSE 250 index is up 20 points to 5,386.
Isoft is up 11.5p to 366.5p after Torex, the company it is bidding to take over, reported a surge in first half profit, sending its shares up 12.5p to 591p.
Shares did well in New York overnight.
The Dow Jones Industrial Average index gained 92.71 points to 9,310.06.
The S&P 500 index gained 9.76 points to 990.35, and Nasdaq's Composite index closed up 25.50 points at 1,687.01.
Tokyo's Nikkei 225 index added 187.94 points to 9,752.75, while Hong Kong's Hang Seng index is up 117 points at 10.292.
Regular reminders and updates
9 December 2019 deadline
Joe McDonnell joins as head of portfolio solutions (EMEA)
Adviser of the Year - South East
Fidelity Multi Asset CIO's outlook